This was mainly related to the glomerular hemodynamic effect of the class that leads to a characteristic drop in GFR during the first days after its introduction.3 Consequently, several groups turned their attention to evaluating data on AKI after the use of SGLT2 inhibitors. The gene discussed is SLC5A2; the disease is acute kidney injury.